Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
In this study patients will be treated with 6 weeks of radiation therapy plus temozolomide chemotherapy according to the standard of care. However, the radiation treatment plan will be modified to deliver an higher than routine radiation dose to the subventricular zone which is an area of the brain that contains stem cells that some scientists believe may contribute to glioblastoma recurrence. The purpose of the study is to see if the tumor is controlled for a longer period of time in patients t
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Check if you qualify for this glioblastoma clinical trial in Washington Dc, DC
If you're searching for glioblastoma treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.